• Angiotensin II: Practical Research Protocol

  2026-08-14

  Angiotensin II provides a controlled peptide stimulus for receptor-signaling studies, vascular smooth muscle cell hypertrophy research, and vascular remodeling models. This guide explains preparation, cell and minipump workflows, and quality controls; the product is for research use only and should not be used for diagnosis, treatment, or direct clinical dosing.

• Olsalazine Sodium: Cancer and Transport Workflows

  2026-08-13

  Olsalazine Sodium combines a water-soluble mesalamine dimer format with documented activity in LTB4-driven inflammation and colorectal cancer models. This practical guide connects macrophage chemotaxis, tumor-response assays, and an emerging Aedes aegypti xenobiotic-clearance workflow while emphasizing controls, solubility, and interpretation limits.

• Ciclesonide for Respiratory Cell Assays

  2026-08-13

  Ciclesonide offers a practical way to model prodrug activation, glucocorticoid receptor signaling, and airway inflammation in bronchial epithelial systems. This workflow also shows how to use the compound as a respiratory pharmacology benchmark while keeping it mechanistically distinct from the ERAD-engaging degraders described in recent targeted protein degradation research.

• Diminazene Aceturate: From Parasites to ACE2

  2026-08-12

  Diminazene Aceturate is more than a trypanocidal research reagent: it can also serve as a mechanistic probe in ACE2 activation research. This article presents an evidence-led framework for connecting parasite phenotypes with MasR-Sirt1 signaling and mitochondrial biogenesis studies without conflating distinct biological applications.

• Thioredoxin Control of CHK1 Inhibitor Sensitivity

  2026-08-12

  The reference study identifies thioredoxin 1 and thioredoxin reductase activity as determinants of CHK1 inhibitor response in non-small cell lung cancer models. Its central mechanistic advance is linking redox recycling of RRM1, ribonucleotide reductase function, and deoxynucleotide availability, providing a rationale for combining CHK1 inhibition with thioredoxin reductase blockade.

• Chemistry of Silybin: Structure, Derivatives, and Methods

  2026-08-11

  Křen and colleagues’ review integrates more than five decades of research on silybin, clarifying its flavonolignan structure, absolute configuration, diastereomer separation, and extensive derivative chemistry. Its main practical contribution is a chemical framework for distinguishing pure silybin from the complex milk thistle extract silymarin when designing mechanistic, analytical, and bioactivity studies.

• MRT68921 dual autophagy kinase ULK1/2 inhibitor

  2026-08-10

  A scenario-driven guide to using MRT68921 dual autophagy kinase ULK1/2 inhibitor (SKU B6174) in cell viability, proliferation, and cytotoxicity workflows. It explains mechanism, solvent compatibility, protocol optimization, interpretation of LC3 flux and ATG13 phosphorylation, and practical product-selection criteria.

• Anti-RPS6 Antibody: PDAC Workflow Guide

  2026-08-09

  Build reproducible Western blot, immunofluorescence, and immunoprecipitation workflows around total RPS6 as a practical readout of translational activity. This guide connects the reagent to LRRC8A–CAV1-driven pancreatic cancer biology while separating evidence-backed findings from assay optimization recommendations.

• BAPTA for Calcium Causality in Cell Assays

  2026-08-08

  BAPTA is a high-affinity calcium chelator that helps researchers test whether calcium elevation is causal in apoptosis and signaling phenotypes. This guide develops a causality-first assay framework grounded in recent IP3R/Ca2+/STAT3 toxicology findings, with practical guidance on controls, interpretation, and product handling.

• Iptacopan (LNP023) in Complement Assays

  2026-08-07

  Iptacopan (LNP023) enables selective alternative-pathway C3bBb inhibition without broadly suppressing classical or lectin pathway initiation. This guide translates its factor B pharmacology into reproducible serum, hemolysis, deposition, and translational disease-model workflows.

• Go 6983 Pan-PKC Inhibitor: Optimizing PKC Pathway Research

  2026-08-07

  Go 6983 (pan-PKC inhibitor) enables precise and reproducible modulation of PKC-dependent signaling, accelerating discovery from cancer progression to neurobehavioral models. This guide translates breakthrough mechanistic insights and recent protocol advances into actionable workflows, troubleshooting tips, and competitive advantages for advanced PKC signaling pathway research.

• TNF-alpha Recombinant Murine Protein for Apoptosis Research

  2026-08-06

  Unlock precision in cell death and inflammation assays with TNF-alpha recombinant murine protein. This article delivers actionable protocols, troubleshooting tactics, and leverages cutting-edge apoptosis insights from recent RNA Pol II signaling research.

• Translating PDGF Receptor Inhibition: Strategic Insights wit

  2026-08-06

  This thought-leadership article explores the mechanistic underpinnings and translational applications of JNJ-10198409, a high-potency PDGF-BB receptor inhibitor. By examining the latest evidence from tumor and fibrosis models, contextualizing findings within contemporary kinase signaling research, and addressing workflow optimization for translational scientists, the article provides actionable guidance and a forward-looking perspective. Distinct from standard product summaries, it bridges mechanistic detail with strategic protocol advice and connects to recent advances in host-pathogen signaling, highlighting both the competitive landscape and future directions.

• Neomycin Sulfate: Precision Tool for RNA/DNA and Channel Ass

  2026-08-05

  Neomycin sulfate stands out as a multifunctional aminoglycoside antibiotic, enabling precise modulation of RNA/DNA structures and ryanodine channel activity. This guide details optimized workflows, experimental insights, and troubleshooting strategies for advanced molecular biology and immunology research.

• Cytochalasin B (SKU C4939): Precision Cytoskeletal Research

  2026-08-05

  This article delivers a scenario-driven, evidence-backed exploration of Cytochalasin B (SKU C4939) for biomedical researchers and technicians facing challenges in cell-based assays. By addressing common workflow issues—from assay reproducibility to vendor reliability—it highlights how APExBIO’s Cytochalasin B provides robust, cost-efficient solutions, with direct links to protocols and quantitative data.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page